Target intelligence / Profile preview

Foot-and-mouth disease virus (FMDV) (FMDV)

Target
FMDV
Molecular classification
Virus, Picornaviridae, Aphthovirus
01

Overview

Foot-and-mouth disease virus (FMDV) is a highly infectious, non-enveloped virus with a positive-sense single-stranded RNA genome, belonging to the Aphthovirus genus of the Picornaviridae family (NCBI Taxonomy ID: 12110). It is the causative agent of foot-and-mouth disease, a severe systemic disease affecting cloven-hoofed animals such as cattle, pigs, and sheep, characterized by high fever and vesicles on the mouth and feet (World Organisation for Animal Health). The FMDV genome encodes a single polyprotein that is post-translationally processed by viral proteases, specifically the L-protease and 3C protease, into functional structural and non-structural proteins (UniProt). Therapeutic strategies primarily focus on vaccines; however, research into small-molecule antivirals targets essential viral components like the RNA-dependent RNA polymerase (3Dpol) and the 3C protease to inhibit replication (PubMed: 25653431). Drugs such as Ribavirin and Favipiravir have demonstrated the ability to induce lethal mutagenesis in the FMDV genome by targeting the 3Dpol enzyme (Journal of Virology). Despite research into antivirals, vaccination remains the cornerstone of FMDV control, though its efficacy is challenged by the existence of seven distinct serotypes (O, A, C, SAT 1, SAT 2, SAT 3, and Asia 1) (Nature Reviews Microbiology).

Other names
AphthovirusFMD virusFoot and mouth disease virus
02

Mechanism of action

Inhibition of viral RNA-dependent RNA polymerase (RdRp) and viral 3C protease

03

Biological functions

Viral replicationHost cell entryViral polyprotein processingRNA synthesis
04

Disease associations

Foot-and-mouth diseaseInfection
05

Safety considerations

High mutation rateSerotype diversityEconomic impactBiosafety Level 3 (BSL-3) requirements
06

Interacting drugs

Ribavirin

3 more in the full profile.

07

Biomarkers

FMDV RNAFMDV VP1 antigenAnti-FMDV antibodies

Beyond the preview

Go deeper on Foot-and-mouth disease virus (FMDV) (FMDV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foot-and-mouth disease virus (FMDV) (FMDV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call